Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) EPS (Basic) (2023 - 2025)

Historic EPS (Basic) for Immunocore Holdings (IMCR) over the last 3 years, with Q3 2025 value amounting to -$0.0.

  • Immunocore Holdings' EPS (Basic) fell 10228.74% to -$0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.57, marking a year-over-year increase of 4000.0%. This contributed to the annual value of -$1.02 for FY2024, which is 956.44% up from last year.
  • Latest data reveals that Immunocore Holdings reported EPS (Basic) of -$0.0 as of Q3 2025, which was down 10228.74% from -$0.2 recorded in Q2 2025.
  • Over the past 5 years, Immunocore Holdings' EPS (Basic) peaked at $0.17 during Q3 2024, and registered a low of -$0.49 during Q1 2024.
  • Moreover, its 3-year median value for EPS (Basic) was -$0.23 (2024), whereas its average is -$0.21.
  • Its EPS (Basic) has fluctuated over the past 5 years, first soared by 75000.0% in 2024, then tumbled by 10228.74% in 2025.
  • Immunocore Holdings' EPS (Basic) (Quarter) stood at -$0.4 in 2023, then dropped by 18.88% to -$0.48 in 2024, then soared by 99.18% to -$0.0 in 2025.
  • Its EPS (Basic) stands at -$0.0 for Q3 2025, versus -$0.2 for Q2 2025 and $0.1 for Q1 2025.